/ 100
Novartis India (NOVARTIND) — Technical Setup
₹1,717.70 +1.49% Range Normal Volatility Strong bearish
Summary
Novartis India is in a range on the daily chart. RSI(14) is 40.4, MACD is below its signal line, ADX reads 25. Volume in the latest session was 0.9× its 20-day average. Over three months it has outperformed the Nifty 50 by 15.6 percentage points. Nearest support is ₹1,658.65 and resistance ₹1,900.00. Its technical score is 23/100 (strong bearish).
🧮 How the 23/100 is built
Five components, 20 points each. Every rule is shown with the points it earned — the score describes the chart as it stands today; it is not a prediction.
- Close above 20-day EMA (-6.97)0/3
- 20-day EMA above 50-day EMA3/3
- 50-day EMA above 200-day EMA0/3
- Close above 200-day SMA0/3
- SuperTrend (10,3) pointing up0/3
- ADX ≥ 20 with +DI above −DI (trend has strength) (24.62)0/3
- Weekly trend up (above a rising 30-week average)0/2
- RSI(14) in the bullish zone (55-70 best) (40.42)2/6
- MACD line above its signal line0/4
- MACD line above zero (-44.81)0/3
- 12-day rate of change positive (-13.61)0/3
- Stochastic %K above %D0/2
- Outperforming the Nifty 50 over 3 months (15.62)2/2
- On-balance volume rising over 20 sessions0/5
- Chaikin Money Flow (20) positive (-0.28)0/5
- More volume on up days than down days (20 sessions) (1.21)5/5
- Close above 20-day VWAP (-10.24)0/5
- Daily range (ATR%) contained — ≤2.5% scores full (6.54)0/6
- Price in the upper half of its Bollinger Bands (0.13)0/5
- Shallow drawdown from the 52-week high (-33.65)1/5
- Volatility contracting (20-day volatility below its 6-month median) (64.00)0/4
- Room to the next resistance (≥8% scores full) (10.61)5/5
- Support close below (a tight, definable stop) (3.44)5/5
- Broke above a 20-day high in the last 5 sessions0/5
- Within 5% of the 52-week high (-33.65)0/5
🧭 Regime: Range
Normal Volatility — Bollinger width is in the 62th percentile of the last six months.
Suits: Mean reversion / range trading. No directional edge: buy near range support, sell near resistance, and treat breakouts with suspicion until volume confirms them.
Classified from ADX, the 20/50-day EMA stack and price's distance from the 50-day average; volatility from band-width and ATR expansion.
Opens the AI Backtester with the Bollinger Band Reversion rules for NOVARTIND — close below the lower bollinger band (20,2) while above the 200-day sma.
🕰️ Multi-timeframe
| Timeframe | Trend | RSI (14) | MACD hist. |
|---|---|---|---|
| Monthly | — | — | — |
| Weekly | — | — | — |
| Daily | ◆ Neutral | 40.42 | -24.68 |
Weekly: close vs a rising 30-week average (Weinstein). Monthly: close vs the 10-month average. Weekly SuperTrend: —, weekly ADX —.
📶 Volume & VWAP
VWAPs are computed from daily bars (typical price × volume), not intraday ticks. Volume has dried up to under 60% of normal. Price fell over 20 sessions while OBV rose (bullish price-volume divergence).
💪 Relative strength
NOVARTIND ÷ Nifty 50, rebased to 100 a year ago. Rising = outperforming.
🧱 Support & resistance
Clustered swing highs and lows from the last year; “touches” is how many swings formed the level.
| Level | Price | Distance | Touches |
|---|---|---|---|
| Resistance | ₹2,588.80 | +50.7% | 1 |
| Resistance | ₹2,161.50 | +25.8% | 1 |
| Resistance | ₹1,900.00 | +10.6% | 1 |
| Close | ₹1,717.70 | — | |
| Support | ₹1,658.65 | −3.4% | 8 |
| Support | ₹1,402.00 | −18.4% | 1 |
| Support | ₹1,275.00 | −25.8% | 3 |
| Support | ₹1,059.90 | −38.3% | 1 |
52-week range: ₹950.00 – ₹2,588.80 (-33.65% from the high).
🌀 Fibonacci
Measuring the up-swing from ₹1,013.00 (2026-05-04) to ₹2,588.80 (2026-09-10). Price has retraced 55.3% of it.
| Ratio | Price | Distance | |
|---|---|---|---|
| 23.6% retracement | ₹2,216.91 | +29.1% | |
| 38.2% retracement | ₹1,986.84 | +15.7% | |
| 50.0% retracement | ₹1,800.90 | +4.8% | nearest |
| 61.8% retracement | ₹1,614.96 | -6.0% | |
| 78.6% retracement | ₹1,350.22 | -21.4% | |
| 127.2% extension | ₹3,017.42 | +75.7% | |
| 161.8% extension | ₹3,562.64 | +107.4% | |
| 200.0% extension | ₹4,164.60 | +142.4% |
🕯️ Candlesticks (last 5 sessions)
- Doji 2026-11-02 neutral Weak · 20
- Bullish Harami 2026-11-02 bullish Moderate · 60
Quality combines the pattern's reliability with its context: prior trend, volume, a support/resistance level and RSI.
↗️ Divergences
- OBV bullish 2026-10-01 → 2026-10-23₹1,900.00 → ₹1,642.20
- MFI(14) bullish 2026-10-01 → 2026-10-23₹1,900.00 → ₹1,642.20
- Stochastic %K bullish 2026-10-01 → 2026-10-23₹1,900.00 → ₹1,642.20
✅ Screens NOVARTIND passes today
| Stock | Close | Chg | Score | Trend regime | RS rating (1-99) |
|---|---|---|---|---|---|
| DIVISLABDivi's Laboratories Limited | ₹9,945.50 | +1.69% | 94 | Uptrend | 92.00 |
| ACUTAASAcutaas Chemicals Limited | ₹3,892.60 | -2.77% | 87 | Uptrend | 96.00 |
| SMSPHARMASMS Pharmaceuticals Limited | ₹504.15 | -1.41% | 87 | Strong Uptrend | 92.00 |
| CORONACORONA Remedies Limited | ₹2,171.10 | +1.00% | 86 | Uptrend | 84.00 |
| ZYDUSLIFEZydus Lifesciences Limited | ₹1,240.50 | -0.40% | 85 | Uptrend | 85.00 |
| PPLPHARMAPiramal Pharma Limited | ₹239.92 | +0.42% | 83 | Strong Uptrend | 90.00 |
| DRREDDYDr. Reddy's Laboratories Limited | ₹1,342.00 | -0.74% | 82 | Strong Uptrend | 76.00 |
| AARTIDRUGSAarti Drugs Limited | ₹453.80 | +4.27% | 81 | Strong Uptrend | 77.00 |
| ALIVUSAlivus Life Sciences Limited | ₹1,447.60 | +2.28% | 81 | Strong Uptrend | 92.00 |
| GLANDGland Pharma Limited | ₹3,066.60 | -0.95% | 80 | Uptrend | 94.00 |
⚠️ Educational technical analysis computed automatically from end-of-day NSE prices — not investment advice. Flash Finance is not SEBI-registered. Indicators describe what price has done; they do not predict what it will do. Verify levels on a live chart and manage risk before acting.
